BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17349618)

  • 1. The importance of 3,4-epoxy-1,2-butanediol and hydroxymethylvinyl ketone in 3-butene-1,2-diol associated mutagenicity.
    Powley MW; Walker VE; Li Y; Upton PB; Swenberg JA
    Chem Biol Interact; 2007 Mar; 166(1-3):182-90. PubMed ID: 17349618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol.
    Powley MW; Li Y; Upton PB; Walker VE; Swenberg JA
    Carcinogenesis; 2005 Sep; 26(9):1573-80. PubMed ID: 15888494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,N2-propanodeoxyguanosine adducts of the 1,3-butadiene metabolite, hydroxymethylvinyl ketone.
    Powley MW; Jayaraj K; Gold A; Ball LM; Swenberg JA
    Chem Res Toxicol; 2003 Nov; 16(11):1448-54. PubMed ID: 14615971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of plasma or urinary metabolites and Hprt mutant frequencies following inhalation exposure of mice and rats to 3-butene-1,2-diol.
    Walker DM; McDonald JD; Meng Q; Kracko DA; Bauer MJ; Seilkop SK; Walker EL; Henderson RF; Walker VE
    Chem Biol Interact; 2007 Mar; 166(1-3):191-206. PubMed ID: 17316587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
    Blair IA; Oe T; Kambouris S; Chaudhary AK
    Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
    Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE;
    Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.
    Koc H; Tretyakova NY; Walker VE; Henderson RF; Swenberg JA
    Chem Res Toxicol; 1999 Jul; 12(7):566-74. PubMed ID: 10409395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectral analyses of hemoglobin adducts formed after in vitro exposure of erythrocytes to hydroxymethylvinyl ketone.
    Barshteyn N; Krause RJ; Elfarra AA
    Chem Biol Interact; 2007 Mar; 166(1-3):176-81. PubMed ID: 16735035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
    Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
    Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mercapturic acid urinary metabolites of 3-butene-1,2-diol as in vivo evidence for the formation of hydroxymethylvinyl ketone in mice and rats.
    Sprague CL; Elfarra AA
    Chem Res Toxicol; 2004 Jun; 17(6):819-26. PubMed ID: 15206903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-, gender-, and species-dependent mutagenicity in T cells of mice and rats exposed by inhalation to 1,3-butadiene.
    Meng Q; Walker DM; McDonald JD; Henderson RF; Carter MM; Cook DL; McCash CL; Torres SM; Bauer MJ; Seilkop SK; Upton PB; Georgieva NI; Boysen G; Swenberg JA; Walker VE
    Chem Biol Interact; 2007 Mar; 166(1-3):121-31. PubMed ID: 16945358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPLC-ESI+-MS/MS analysis of N7-guanine-N7-guanine DNA cross-links in tissues of mice exposed to 1,3-butadiene.
    Goggin M; Loeber R; Park S; Walker V; Wickliffe J; Tretyakova N
    Chem Res Toxicol; 2007 May; 20(5):839-47. PubMed ID: 17455958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
    Albertini RJ; Sram RJ; Vacek PM; Lynch J; Rossner P; Nicklas JA; McDonald JD; Boysen G; Georgieva N; Swenberg JA
    Chem Biol Interact; 2007 Mar; 166(1-3):63-77. PubMed ID: 16949064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectral analyses of hydroxymethylvinyl ketone-hemoglobin adducts formed after in vivo exposure of Sprague-Dawley rats to 3-butene-1,2-diol.
    Barshteyn N; Elfarra AA
    Chem Res Toxicol; 2009 Jun; 22(6):1163-71. PubMed ID: 19419228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bis-butanediol-mercapturic acid (bis-BDMA) as a urinary biomarker of metabolic activation of butadiene to its ultimate carcinogenic species.
    Kotapati S; Sangaraju D; Esades A; Hallberg L; Walker VE; Swenberg JA; Tretyakova NY
    Carcinogenesis; 2014 Jun; 35(6):1371-8. PubMed ID: 24531806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene.
    Booth ED; Kilgour JD; Watson WP
    Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study.
    Albertini RJ; Srám RJ; Vacek PM; Lynch J; Nicklas JA; van Sittert NJ; Boogaard PJ; Henderson RF; Swenberg JA; Tates AD; Ward JB; Wright M; Ammenheuser MM; Binkova B; Blackwell W; de Zwart FA; Krako D; Krone J; Megens H; Musilová P; Rajská G; Ranasinghe A; Rosenblatt JI; Rössner P; Rubes J; Sullivan L; Upton P; Zwinderman AH
    Res Rep Health Eff Inst; 2003 Jun; (116):1-141; discussion 143-62. PubMed ID: 12931846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
    Pianalto KM; Hartman JH; Boysen G; Miller GP
    Toxicol Lett; 2013 Nov; 223(2):221-7. PubMed ID: 24021170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.